Literature DB >> 10085680

Vulvovaginitis due to Candida glabrata. An emerging problem.

J D Sobel1.   

Abstract

A review is presented of the emerging problem of resistant and chronic vaginitis due to Candida glabrata. Although accurate numbers are lacking, several investigators report encountering increased numbers of women with vaginitis due to C. glabrata. Possible reasons for this apparent increase are discussed. Risk factors and clinical manifestations of symptomatic C. glabrata vaginitis differ from those of C. albicans, C. glabrata being less susceptible to fungistatic azole agents is more difficult to eradicate. Successful management of chronic C. glabrata vaginitis constitutes a major challenge with currently available therapeutic agents.

Entities:  

Mesh:

Year:  1998        PMID: 10085680     DOI: 10.1111/j.1439-0507.1998.tb00594.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  12 in total

1.  Management of Infections Caused by Candida glabrata.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

2.  Probiotic Properties of Lactobacillus crispatus 2,029: Homeostatic Interaction with Cervicovaginal Epithelial Cells and Antagonistic Activity to Genitourinary Pathogens.

Authors:  Vyacheslav Abramov; Valentin Khlebnikov; Igor Kosarev; Guldana Bairamova; Raisa Vasilenko; Natalia Suzina; Andrey Machulin; Vadim Sakulin; Natalia Kulikova; Nadezhda Vasilenko; Andrey Karlyshev; Vladimir Uversky; Michael L Chikindas; Vyacheslav Melnikov
Journal:  Probiotics Antimicrob Proteins       Date:  2014-12       Impact factor: 4.609

3.  Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013).

Authors:  W Mendling; K Friese; I Mylonas; E-R Weissenbacher; J Brasch; M Schaller; P Mayser; I Effendy; G Ginter-Hanselmayer; H Hof; O Cornely; M Ruhnke
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

4.  A simplified technique for evaluating the adherence of yeasts to human vaginal epithelial cells.

Authors:  Mary Mayumi Taguti Irie; Márcia Edilaine Lopes Consolaro; Terezinha Aparecida Guedes; Lucélia Donatti; Eliana Valéria Patussi; Terezinha Inez Estivalet Svidzinski
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

5.  Susceptibility profile of vaginal yeast isolates from Brazil.

Authors:  M A Ribeiro; R Dietze; C R Paula; D A Da Matta; A L Colombo
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

Review 6.  [Mycotic infections of the anogenital region].

Authors:  P Mayser; W Hort; S Pflieger-Bruss
Journal:  Hautarzt       Date:  2005-06       Impact factor: 0.751

7.  Vulvovaginal Candidosis (Excluding Mucocutaneous Candidosis): Guideline of the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry Number 015/072, September 2020).

Authors:  Alex Farr; Isaak Effendy; Brigitte Frey Tirri; Herbert Hof; Peter Mayser; Ljubomir Petricevic; Markus Ruhnke; Martin Schaller; Axel P A Schäfer; Birgit Willinger; Werner Mendling
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-04-14       Impact factor: 2.915

8.  Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia.

Authors:  Monika Sojakova; Denisa Liptajova; Miroslav Borovsky; Julius Subik
Journal:  Mycopathologia       Date:  2004-02       Impact factor: 2.574

9.  Prevalence and exoenzyme secretion by Candida albicans isolates from oral and vaginal mucosas of HIV-infected women.

Authors:  Mariceli Araujo Ribeiro; Angelica Espinosa Miranda; Walderez Gambale; Claudete Rodrigues Paula
Journal:  Mycopathologia       Date:  2004-04       Impact factor: 2.574

10.  Efficient diagnosis of vulvovaginal candidiasis by use of a new rapid immunochromatography test.

Authors:  Agnes Marot-Leblond; Sandrine Nail-Billaud; Françoise Pilon; Bertrand Beucher; Daniel Poulain; Raymond Robert
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.